pdufa date for tirzepatide Prescription Drug User Fee Act (PDUFA): 2017 Reauthorization as VI Upcoming Generics Provide New Considerations
Description
Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm

A sustainable rate of 0.5 to 1 percent of body weight per week indicates effective dosing
When To Contact Your Healthcare Provider Call your provider if fatigue is severe, gets worse, or comes with: Fainting Chest pain Marked dizziness Confusion Symptoms of low blood sugar Also seek care if nausea, vomiting, or diarrhea prevent you from keeping fluids down, or if you have new signs of depression or sleep apnea symptoms

For Zepbound, recommended maintenance doses are 5 mg, 10 mg, and 15 mg (with 7.5 mg and 12.5 mg serving as titration steps)

use a clean, dry area each time
